{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T11:58:31Z","timestamp":1790423911996,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2015,8,28]],"date-time":"2015-08-28T00:00:00Z","timestamp":1440720000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2015,8,28]],"date-time":"2015-08-28T00:00:00Z","timestamp":1440720000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Blood Cancer Journal"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Monoclonal gammopathies of undetermined significance (MGUS) have been shown to be associated with an increased risk of fractures. This study describes prospectively the bone status of MGUS patients and determines the factors associated with vertebral fracture. We included prospectively 201 patients with MGUS, incidentally discovered, and with no known history of osteoporosis: mean age 66.6\u00b112.5 years, 48.3% women, 51.7% immunoglobulin G (IgG), 33.3% IgM and 10.4% IgA. Light chain was kappa in 64.2% patients. All patients had spinal radiographs and bone mineral density measurement in addition to gammopathy assessment. At least one prevalent non-traumatic vertebral fracture was discovered in 18.4% patients and equally distributed between men and women. Fractured patients were older, had a lower bone density and had also more frequently a lambda light chain isotype. Compared with patients with \u03ba light chain, the odds ratio of being fractured for patients with \u03bb light chain was 4.32 (95% confidence interval 1.80\u201311.16;<jats:italic>P<\/jats:italic>=0.002). These results suggest a high prevalence of non-traumatic vertebral fractures in MGUS associated with lambda light chain isotype and not only explained by low bone density.<\/jats:p>","DOI":"10.1038\/bcj.2015.71","type":"journal-article","created":{"date-parts":[[2015,8,28]],"date-time":"2015-08-28T13:21:59Z","timestamp":1440768119000},"page":"e345-e345","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Factors associated with an increased risk of vertebral fracture in monoclonal gammopathies of undetermined significance"],"prefix":"10.1038","volume":"5","author":[{"given":"J M","family":"Piot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Royer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Schmidt-Tanguy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Hopp\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Gardembas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Bourr\u00e9e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Hunault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Fran\u00e7ois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Boyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Ifrah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Renier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Chevailler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Audran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Chappard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Libouban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Mabilleau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Legrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Bouvard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,8,28]]},"reference":[{"key":"BFbcj201571_CR1","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1111\/j.1365-2141.2006.06235.x","volume":"134","author":"RA Kyle","year":"2006","unstructured":"Kyle RA, Rajkumar SV . Monoclonal gammopathy of undetermined significance. Br J Haematol 2006; 134: 573\u2013589.","journal-title":"Br J Haematol"},{"key":"BFbcj201571_CR2","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1056\/NEJMoa01133202","volume":"346","author":"RA Kyle","year":"2002","unstructured":"Kyle RA, Therneau TM, Rajkumar SV, Offord JR, Larson DR, Plevak MF et al. A long-term study of prognosis in monoclonal gammopathy of undetermined significance. N Engl J Med 2002; 346: 564\u2013569.","journal-title":"N Engl J Med"},{"key":"BFbcj201571_CR3","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1200\/JCO.2012.47.7901","volume":"31","author":"E Terpos","year":"2013","unstructured":"Terpos E, Morgan G, Dimopoulos MA, Drake MT, Lentzsch S, Raje N et al. International Myeloma Working Group recommendations for the treatment of multiple myeloma-related bone disease. J Clin Oncol 2013; 31: 2347\u20132357.","journal-title":"J Clin Oncol"},{"key":"BFbcj201571_CR4","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/j.1365-2141.2006.06269.x","volume":"135","author":"H Gregersen","year":"2006","unstructured":"Gregersen H, Jensen P, Gislum M, J\u00f8rgensen B, S\u00f8rensen HT, N\u00f8rgaard M . Fracture risk in patients with monoclonal gammopathy of undetermined significance. Br J Haematol 2006; 135: 62\u201367.","journal-title":"Br J Haematol"},{"key":"BFbcj201571_CR5","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1359\/jbmr.0301212","volume":"19","author":"LJ Melton 3rd","year":"2004","unstructured":"Melton LJ 3rd, Rajkumar SV, Khosla S, Achenbach SJ, Oberg AL, Kyle RA . Fracture risk in monoclonal gammopathy of undetermined significance. J Bone Miner Res 2004; 19: 25\u201330.","journal-title":"J Bone Miner Res"},{"key":"BFbcj201571_CR6","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1002\/jbmr.2387","volume":"29","author":"MT Drake","year":"2014","unstructured":"Drake MT . Unveiling skeletal fragility in patients diagnosed with MGUS: no longer a condition of undetermined significance? J Bone Miner Res 2014; 29: 2529\u20132533.","journal-title":"J Bone Miner Res"},{"key":"BFbcj201571_CR7","doi-asserted-by":"publisher","first-page":"30S","DOI":"10.1016\/S0002-9343(97)90025-5","volume":"103","author":"PD Ross","year":"1997","unstructured":"Ross PD . Clinical consequences of vertebral fractures. Am J Med 1997; 103: 30S\u201342S.","journal-title":"Am J Med"},{"key":"BFbcj201571_CR8","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/jbmr.5650070214","volume":"7","author":"C Cooper","year":"1992","unstructured":"Cooper C, Atkinson EJ, O'Fallon M, Melton LJ . Incidence of clinically diagnosed vertebral fractures: a population-based study in Rochester, Minnesota, 1985-1989. J Bone Miner Res 1992; 7: 221\u2013227.","journal-title":"J Bone Miner Res"},{"key":"BFbcj201571_CR9","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.bone.2012.09.023","volume":"52","author":"A El Maghraoui","year":"2013","unstructured":"El Maghraoui A, Rezqi A, Mounach A, Achemlal L, Bezza A, Ghozlani I . Systematic vertebral fracture assessment in asymptomatic postmenopausal women. Bone 2013; 52: 176\u2013180.","journal-title":"Bone"},{"key":"BFbcj201571_CR10","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1001\/jama.285.3.320","volume":"285","author":"R Lindsay","year":"2001","unstructured":"Lindsay R, Silverman SL, Cooper C, Hanley DA, Barton I, Broy SB et al. Risk of new vertebral fracture in the year following a fracture. JAMA 2001; 285: 320\u2013323.","journal-title":"JAMA"},{"key":"BFbcj201571_CR11","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1007\/s001980050218","volume":"10","author":"LJ Melton 3rd","year":"1999","unstructured":"Melton LJ 3rd, Atkinson EJ, Cooper C, O\u2019Fallon WM, Riggs BL . Vertebral fractures predict subsequent fractures. Osteoporos Int 1999; 10: 214\u2013221.","journal-title":"Osteoporos Int"},{"key":"BFbcj201571_CR12","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.bone.2004.03.024","volume":"35","author":"JA Kanis","year":"2004","unstructured":"Kanis JA, Johnell O, De Laet C, Johansson H, Oden A, Delmas P et al. A meta-analysis of previous fracture and subsequent fracture risk. Bone 2004; 35: 375\u2013382.","journal-title":"Bone"},{"key":"BFbcj201571_CR13","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1365-2141.2010.08207.x","volume":"150","author":"JR Berenson","year":"2010","unstructured":"Berenson JR, Anderson KC, Audell RA, Boccia RV, Coleman M, Dimopoulos MA et al. Monoclonal gammopathy of undetermined significance: a consensus statement. Br J Haematol 2010; 150: 28\u201338.","journal-title":"Br J Haematol"},{"key":"BFbcj201571_CR14","doi-asserted-by":"publisher","first-page":"984","DOI":"10.3324\/haematol.2013.100552","volume":"99","author":"NWCJ Van de Donk","year":"2014","unstructured":"Van de Donk NWCJ, Palumbo A, Johnsen HE, Engelhardt M, Gay F, Gregersen H et al. The clinical relevance and management of monoclonal gammopathy of undetermined significance and related disorders: recommendations from the European Myeloma Network. Haematologica 2014; 99: 984\u2013996.","journal-title":"Haematologica"},{"key":"BFbcj201571_CR15","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1046\/j.1365-2141.2003.04355.x","volume":"121","author":"International Myeloma Working Group","year":"2003","unstructured":"International Myeloma Working Group. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. Br Journal Haematol 2003; 121: 749\u2013757.","journal-title":"Br Journal Haematol"},{"key":"BFbcj201571_CR16","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1002\/jbmr.5650080915","volume":"8","author":"HK Genant","year":"1993","unstructured":"Genant HK, Wu CY, van Kuijk C, Nevitt MC . Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 1993; 8: 1137\u20131148.","journal-title":"J Bone Miner Res"},{"key":"BFbcj201571_CR17","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.revmed.2007.04.011","volume":"28","author":"O Decaux","year":"2007","unstructured":"Decaux O, Rodon P, Ruelland A, Estepa L, Leblay R, Grosbois B . Epidemiology of monoclonal gammopathy in a general hospital and a university internal medicine department. Rev Med Interne 2007; 28: 670\u2013676.","journal-title":"Rev Med Interne"},{"key":"BFbcj201571_CR18","first-page":"557","volume":"56","author":"D Hurez","year":"1985","unstructured":"Hurez D, Youinou P, Gombert J, Preud\u2019Homme JL . Survey of monoclonal gammopathy in western France: incidence and unexpected high frequency of IgM. Immunology 1985; 56: 557\u2013560.","journal-title":"Immunology"},{"key":"BFbcj201571_CR19","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1002\/jbmr.5650110719","volume":"11","author":"TW O'Neill","year":"1996","unstructured":"O'Neill TW, Felsenberg D, Varlow J, Cooper C, Kanis JA, Silman AJ, and the European vertebral osteoporosis study group. The prevalence of vertebral deformityin european men and women: the european vertebral osteoporosis study group. J Bone Miner Res 1996; 11: 1010\u20131018.","journal-title":"J Bone Miner Res"},{"key":"BFbcj201571_CR20","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1182\/blood-2013-05-505776","volume":"123","author":"JN Farr","year":"2014","unstructured":"Farr JN, Zhang W, Kumar SK, Jacques RM, Ng AC, McCready LK et al. Altered cortical microarchitecture in patients with monoclonal gammopathy of undetermined significance. Blood 2014; 123: 647\u2013649.","journal-title":"Blood"},{"key":"BFbcj201571_CR21","doi-asserted-by":"publisher","first-page":"685","DOI":"10.4065\/84.8.685","volume":"84","author":"JP Bida","year":"2009","unstructured":"Bida JP, Kyle RA, Therneau TM, Melton LJ 3rd, Plevak MF, Larson DR et al. Disease associations with monoclonal gammopathy of undetermined significance: a population-based study of 17,398 patients. Mayo Clin Proc 2009; 84: 685\u2013693.","journal-title":"Mayo Clin Proc"},{"key":"BFbcj201571_CR22","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1182\/blood-2010-04-282848","volume":"116","author":"SY Kristinsson","year":"2010","unstructured":"Kristinsson SY, Tang M, Pfeiffer RM, Bj\u00f6rkholm M, Blimark C, Mellqvist UH et al. Monoclonal gammopathy of undetermined significance and risk of skeletal fractures: a population-based study. Blood 2010; 116: 2651\u20132655.","journal-title":"Blood"},{"key":"BFbcj201571_CR23","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1111\/j.1365-2141.2006.06217.x","volume":"134","author":"J Pepe","year":"2006","unstructured":"Pepe J, Petrucci MT, Nofroni I, Fassino V, Diacinti D, Romagnoli E et al. Lumbar bone mineral density as the major factor determining increased prevalence of vertebral fractures in monoclonal gammopathy of undetermined significance. Br J Haematol 2006; 134: 485\u2013490.","journal-title":"Br J Haematol"},{"key":"BFbcj201571_CR24","doi-asserted-by":"publisher","first-page":"3034","DOI":"10.1073\/pnas.91.8.3034","volume":"91","author":"EA Myatt","year":"1994","unstructured":"Myatt EA, Westholm FA, Weiss DT, Solomon A, Schiffer M, Stevens FJ . Pathogenic potential of human monoclonal immunoglobulin light chains: relationship of in vitro aggregation to in vivo organ deposition. Proc Natl Acad Sci USA 1994; 91: 3034\u20133038.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFbcj201571_CR25","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.2215\/CJN.02740806","volume":"1","author":"V Sanchorawala","year":"2006","unstructured":"Sanchorawala V . Light-chain (AL) amyloidosis: diagnosis and treatment. Clin J Am Soc Nephrol 2006; 1: 1331\u20131341.","journal-title":"Clin J Am Soc Nephrol"},{"key":"BFbcj201571_CR26","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1002\/ajh.22050","volume":"86","author":"A Dispenzieri","year":"2011","unstructured":"Dispenzieri A . POEMS syndrome: 2011 update on diagnosis, risk-stratification, and management. Am J Hematol 2011; 86: 591\u2013601.","journal-title":"Am J Hematol"},{"key":"BFbcj201571_CR27","doi-asserted-by":"publisher","first-page":"3801","DOI":"10.1182\/blood-2002-09-2707","volume":"101","author":"RS Abraham","year":"2003","unstructured":"Abraham RS, Geyer SM, Price-Troska TL, Allmer C, Kyle RA, Gertz MA et al. Immunoglobulin light chain variable (V) region genes influence clinical presentation and outcome in light chain-associated amyloidosis (AL). Blood 2003; 101: 3801\u20133808.","journal-title":"Blood"},{"key":"BFbcj201571_CR28","doi-asserted-by":"crossref","first-page":"4762","DOI":"10.1182\/blood.V87.11.4762.bloodjournal87114762","volume":"87","author":"R Bataille","year":"1996","unstructured":"Bataille R, Chappard D, Basle MF . Quantifiable excess of bone resorption in monoclonal gammopathy is an early symptom of malignancy: a prospective study of 87 bone biopsies. Blood 1996; 87: 4762\u20134769.","journal-title":"Blood"},{"key":"BFbcj201571_CR29","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1182\/blood-2008-01-132134","volume":"112","author":"Y-W Qiang","year":"2008","unstructured":"Qiang Y-W, Chen Y, Stephens O, Brown N, Chen B, Epstein J et al. Myeloma-derived Dickkopf-1 disrupts Wnt-regulated osteoprotegerin and RANKL production by osteoblasts: a potential mechanism underlying osteolytic bone lesions in multiple myeloma. Blood 2008; 112: 196\u2013207.","journal-title":"Blood"},{"key":"BFbcj201571_CR30","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1046\/j.1365-2141.2002.03417.x","volume":"117","author":"S Roux","year":"2002","unstructured":"Roux S, Meignin V, Quillard J, Meduri G, Guiochon-Mantel A, Fermand JP et al. RANK (receptor activator of nuclear factor-kappaB) and RANKL expression in multiple myeloma. Br J Haematol 2002; 117: 86\u201392.","journal-title":"Br J Haematol"},{"key":"BFbcj201571_CR31","doi-asserted-by":"publisher","first-page":"6529","DOI":"10.1182\/blood-2011-04-351437","volume":"118","author":"AC Ng","year":"2011","unstructured":"Ng AC, Khosla S, Charatcharoenwitthaya N, Kumar SK, Achenbach SJ, Holets MF et al. Bone microstructural changes revealed by high-resolution peripheral quantitative computed tomography imaging and elevated DKK1 and MIP-1\u03b1 levels in patients with MGUS. Blood 2011; 118: 6529\u20136534.","journal-title":"Blood"},{"key":"BFbcj201571_CR32","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1111\/j.1365-2141.2004.05092.x","volume":"126","author":"M Politou","year":"2004","unstructured":"Politou M, Terpos E, Anagnostopoulos A, Szydlo R, Laffan M, Layton M et al. Role of receptor activator of nuclear factor-kappa B ligand (RANKL), osteoprotegerin and macrophage protein 1-alpha (MIP-1a) in monoclonal gammopathy of undetermined significance (MGUS). Br J Haematol 2004; 126: 686\u2013689.","journal-title":"Br J Haematol"},{"key":"BFbcj201571_CR33","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/j.1365-2141.1990.tb07902.x","volume":"76","author":"JF Rossi","year":"1990","unstructured":"Rossi JF, Chappard D, Marcelli C, Laplante J, Commes T, Baldet P et al. Micro-osteoclast resorption as a characteristic feature of B-cell malignancies other than multiple myeloma. Br J Haematol 1990; 76: 469\u2013475.","journal-title":"Br J Haematol"}],"container-title":["Blood Cancer Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bcj201571.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bcj201571","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bcj201571.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T20:05:35Z","timestamp":1718049935000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bcj201571"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,28]]},"references-count":33,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2015,8]]}},"alternative-id":["BFbcj201571"],"URL":"https:\/\/doi.org\/10.1038\/bcj.2015.71","relation":{},"ISSN":["2044-5385"],"issn-type":[{"value":"2044-5385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,28]]},"assertion":[{"value":"21 February 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}